Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:33 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 193–216 of 360 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Pharmacist intervention Clear all

Conditions: Tobacco Use Cessation, Tobacco Use Disorder, Nicotine Dependence, Smokeless Tobacco Use
Interventions: QuitAid (pharmacist-delivered MTM), Nicotine Replacement Therapy (NRT); Behavioral · Drug
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Older Adults, Anxiety, Depression, Major Surgical Resection of a Thoracic Malignancy, Major Surgical Resection of an Abdominal Malignancy
Interventions: Behavioral Activation, Medication Optimization, Usual care resources; Behavioral · Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 60 Years and older
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Obesity
Interventions: Shared medical appointments for weight loss; Behavioral
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years to 74 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Heart Failure
Interventions: Pharmacist intervention; Behavioral
Lead sponsor: University of North Carolina; Other
Eligibility: 50 Years and older
Enrollment: 314 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2004
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: COVID-19
Interventions: Melatonin, Placebo (Methylcellulose) capsule; Drug · Other
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Contraception, Pharmaceutical Services, Access and Linkage to Healthcare, Technology Use
Interventions: HAPPI software; Other
Lead sponsor: EMPOWERX INC; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Del Mar, California

Conditions: Polypharmacy, Alzheimer Disease and Related Dementias
Interventions: Pharmacist-led deprescribing intervention; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 65 Years and older
Enrollment: 138 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Aurora, Colorado • Baltimore, Maryland

Conditions: Medication Adherence
Interventions: Screening and Brief Intervention (BI), Pill Box (PB); Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 85 Years
Enrollment: 1,091 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 2
States / cities: Marietta, Georgia • Pittsburgh, Pennsylvania

Conditions: Pharmacies, Opioid Use, Patient Safety
Interventions: MOON+; Behavioral
Lead sponsor: Brandeis University; Other
Eligibility: 18 Years and older
Enrollment: 450 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 5
States / cities: Waltham, Massachusetts • Portland, Oregon • Kingston, Rhode Island + 1 more

Conditions: Heart Failure, Chronic Kidney Diseases
Interventions: Multidisciplinary Care Coordination Team; Behavioral
Lead sponsor: George Washington University; Other
Eligibility: 18 Years and older
Enrollment: 96 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Perioperative/Postoperative Complications
Interventions: Pharmacogenomic (PGx), Review results; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 80 Years
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Palliative Medicine
Interventions: Pharmacogenomics testing, Pharmacist review; Diagnostic Test · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Alcohol Use Disorder
Interventions: audit and feedback, educational meetings, and academic detailing to promote medication receipt, Acamprosate, naltrexone, or disulfiram; Behavioral · Drug
Lead sponsor: Yale University; Other
Eligibility: Not listed
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Polypharmacy
Interventions: Bundled hyperpolypharmacy; Other
Lead sponsor: Kaiser Permanente; Other
Eligibility: 76 Years and older
Enrollment: 2,471 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Oakland, California

Conditions: Type 2 Diabetes Mellitus, Acute Kidney Injury, Chronic Kidney Diseases
Interventions: Clinical Decision Support Message; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 30 Years to 75 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Hypertension
Interventions: Home Blood Pressure Monitoring; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years to 85 Years
Enrollment: 348 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Medication Adverse Effects, Older Adults (65 Years and Older), Polypharmacy, Polypharmacy Patients, Deprescribing
Interventions: Patient-tailored deprescribing assessment and intervention; Behavioral
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 65 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Hypertension
Interventions: Research Pharmacist; Behavioral
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Atrial Fibrillation
Interventions: Intervention, Control; Behavioral · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 90 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Cardiovascular Disease
Interventions: oral education & written tips for remembering medications, pill box, pocket medication card, sharing information with community pharmacist, Medication use evaluations by community pharmacist, informing physician if patient has stopped a medication, Routine discharge counseling, Letter to physician/discharge summary; Behavioral · Device · Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 143 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Hypertension
Interventions: GOALS, Minding GOALS; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 21 Years to 79 Years
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Medication Adherence
Interventions: ABM; Other
Lead sponsor: American Pharmacists Association Foundation; Other
Eligibility: 18 Years and older
Enrollment: 595 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 2
States / cities: Phoenix, Arizona • Tucson, Arizona

Conditions: Hypertension, Adherence, Medication
Interventions: Medication Adherence Problem Solving for Hypertension; Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Diabetes, Dyslipidemia, Hypertension, Coronary Atherosclerosis
Interventions: Counseling, Interactive Education, Group Support, Pharmacologic case management; Behavioral · Procedure
Lead sponsor: Providence VA Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2008
U.S. locations: 1
States / cities: Providence, Rhode Island

Search by objective public record fields.

Feasibility of a Medical-Legal Partnership Model to Connect Coal Miners QuitAid

Behavioral Activation and Medication Optimization For Improving Perioperative Mental Health In Older Adults Undergoing Oncologic Surgery

Shared Medical Appointments for Weight Loss

Improving Drug Use for Elderly Heart Failure Patients

Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19

Hormonal Contraception Access Through Pharmacist Prescribing Implementation

Aligning Medications With What Matters Most

Effect of Community Pharmacist Intervention on Adherence to Long-Term Medications

RESPOND TO PREVENT: Stepwise Pharmacy Naloxone Study

Creating A Cardiorenal Multidisciplinary Team for Management HF and CKD Patients

Genomic Opioid Optimization of Dosing and Selections (GOODS) Study

The Role of the Pharmacist and Pharmacogenomics in the Care of Seriously Ill Patients

Promoting Medications for Alcohol Use Disorder on the General Medicine Service

Bundled Hyperpolypharmacy Deprescribing

Clinical Decision Support for SGLT2i After AKI in Type 2 Diabetes

Home Blood Pressure Monitoring Project

Population Health Approach to Optimizing Medications in Older Adults

A Pharmacist Intervention to Improve Mother and Child Health

Dabigatran Adherence Pilot Intervention for Patients With Atrial Fibrillation

Study of an Intervention to Improve Use of Life-saving Medications for Heart Disease

Minding GOALS: An Internet-Assisted Mind-Body-Behavior Program for Blood Pressure Control

ABM for ACO Beneficiaries

Testing Feasibility of Medication Adherence Problem Solving for Hypertension

Strategies to Maintain Cardiac Risk Control After Discharge From Cardiovascular Risk Reduction Clinic